The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection
Chronic hepatitis C virus (HCV) infection is a leading cause of liver disease worldwide and remains the most common indication for liver transplantation. The current standard of care leads to a sustained viral response of roughly 50% of treated patients at best. Furthermore, anti-viral therapy is ex...
Main Authors: | Nazia Selzner, Ahmed Helmy, Katharina Foerster, Oyedele A. Adeyi, David R. Grant, Gary Levy |
---|---|
Format: | Article |
Language: | English |
Published: |
Rambam Health Care Campus
2010-07-01
|
Series: | Rambam Maimonides Medical Journal |
Subjects: | |
Online Access: | http://rmmj.org.il/(S(zxxjbfamyql1hiaqpcgqoz00))/Pages/ArticleHTM.aspx?manuId=5 |
Similar Items
-
sFgl2-Treg Positive Feedback Pathway Protects against Atherosclerosis
by: Tianhui An, et al.
Published: (2023-01-01) -
Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis
by: Xi-Yang Tang, et al.
Published: (2022-10-01) -
Targeting FGL2 in glioma immunosuppression and malignant progression
by: Xiaoyu Ma, et al.
Published: (2022-10-01) -
Development of LAG-3/FGL1 blocking peptide and combination with radiotherapy for cancer immunotherapy
by: Yuzhen Qian, et al.
Published: (2024-03-01) -
FGL2 is positively correlated with enhanced antitumor responses mediated by T cells in lung adenocarcinoma
by: Kai Yuan, et al.
Published: (2020-03-01)